Article information
Full text is only aviable in PDF
Bibliografía
[1.]
E. Middieton Jr..
Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium.
J Pharm Sci, 69 (1980), pp. 243-251
[2.]
E. Middieton Jr..
Role of calcium and calcium antagonists in airway function.
Eur J Respir Dis, 64 (1983), pp. 123-132
[3.]
E. Russi, T. Ahmed.
Calcium and calcium antagonists in airway disease: a review.
Chest, 86 (1984), pp. 475-482
[4.]
T.J. Sullivan, L.J. Brown.
Roles of calcium in mediator reléase from mast cells.
New perspectives on calcium antagonists., pp. 159-168
[5.]
E. Middieton Jr..
Airway smooth muscle, asthma, and calcium ions.
J Allergy Clin Immunol, 73 (1984), pp. 643-650
[7.]
E. Middieton Jr..
Calcium antagonists and asthma.
J Allergy Clin Immunol, 76 (1985), pp. 341-346
[8.]
T. Ahmed, W.M. Abraham.
Role of calcium-channel blockers in obstructive airway disease.
Chest, 88 (1985), pp. 142S-151S
[9.]
Y. Nishizuka.
Protein-kinases in signal transduction.
Trends Biochem Sci, (1984), pp. 163-166
[10.]
W.M. Gold.
Role of cyclic nucleotides in airway smooth muscle.
Physiology and pharmacology of the airways, pp. 123-190
[11.]
E.W. Sutherland, G.S. Robinson, R.W. Butcher.
Some aspects of the biológica! role of adenosine 3’5’-monophosphate (cyclic AMP).
Circulation, 37 (1968), pp. 279-306
[12.]
T.B. Bolton.
Mechanisms of action of transmitters and other substances on smooth muscle.
Physiol Rev, 59 (1979), pp. 606-717
[13.]
M.A. Movsesian.
Calcium physiology in smooth muscle.
Prog Cardiovasc Dis, 25 (1982), pp. 211-224
[14.]
N. Lakshminarayanaiah.
Calcium channeis in the barnacle muscle membrane.
New perspectives on calcium antagonists, pp. 19-33
[15.]
D.J. Trigle.
Biochemical pharmacology of calcium blockers.
Calcium channeis blockers: mechanisms of action and clinical applications, pp. 121-134
[16.]
H. Reuter.
Calcium channel modulation by neurotransmitters, enzymes and drugs.
Nature, 301 (1983), pp. 569-574
[17.]
M.I. Berridge, channels. Receptor-operated calcium.
Handbook Exp Pharmacol, 58 (1982), pp. 227-270
[18.]
T. Godfraind.
Calcium influx and receptor-response coupling.
New perspectives on calcium antagonists, pp. 95-108
[19.]
H. Rasmussen, P.Q. Barret.
Calcium messenger system: an integrated view.
Physiol Rev, 64 (1984), pp. 938-984
[20.]
S.K. Joseph.
Inositol triphosphate: an intracellular messenger produced by Ca2+ mobilizing hormones.
Trends Biochem Sci, 9 (1984), pp. 420-421
[21.]
S.K. Fisher, L.A.A. Van Rooijen, B.W. Agranoff.
Renewed interest in the phasphoinositides.
Trends Biochem Sci, 9 (1984), pp. 53-56
[22.]
K. Hirasawa.
Phosphatidylinositol turnover in receptor mechanism and signal transduction.
Ann Rev Pharmacol Toxicol, 25 (1985), pp. 147-170
[23.]
R.S. Adelstein, D.R. Hathaway.
Role of calcium and cyclic adenosine 3’:5’ monophosphate in regulating smooth muscle contraction. Mechanisms of excitation-contraction coupling in smooth muscle.
Am J Cardiol, 44 (1979), pp. 783-787
[24.]
R.S. Adelstein.
Regulation of contractile proteins by phosphorylation.
J Clin Invest, 72 (1983), pp. 1863-1866
[25.]
K.E. Kamm, J.T. Stull.
The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Ann Rev Pharmacol Toxico!, 25 (1985), pp. 593-620
[26.]
L. Van Breemen, P. Aaronson, R. Loutzenhiser.
Sodiumcalcium interactions in mamaban smooth muscle.
Pharmacol Rev, 30 (1979), pp. 167-208
[27.]
J.P. Morgan, K.G. Morgan.
Vascular smooth muscle: the first recorded Ca2+ transients.
Pfleugers Arch, 395 (1983), pp. 75-77
[28.]
M.O. Aksoy, S. Mras, K.E. Kamm, R.A. Murphy.
Ca2+, cAMP, and changes in myosin phosphorylation during contraction of smooth muscle.
Am J Physiol (cell physiol 14), 245 (1983), pp. C255-C270
[29.]
J.M. Farley, F.R. Miles.
The sources of calcium for acetylcholine-induced contractions of dog tracheal smooth muscle.
J Pharmacol Exp Ther, 207 (1978), pp. 340-346
[30.]
N.L. Stephens, E.A. Kroeger.
Ultrastructure, biophysics, and biochemistry of airway smooth muscle.
Physiology and pharmacology of the airways., pp. 31-122
[31.]
F.R. Goodman.
Calcium-channel blockers and respiratory smooth muscle.
New perspectives on calcium antagonists, pp. 217-222
[32.]
C.H. Fanta, J.M. Drazen.
Calcium blockers and bronchoconstriction.
Am Rev Respir Dis, 127 (1983), pp. 673-674
[33.]
D.J. Trigle, V.C. Swamy.
Pharmacology of agents that affect calcium: agonists and antagonists.
Chest, 78 (suppl) (1980), pp. 174-179
[34.]
D.J. Trigle.
Calcium antagonists: basic chemical and pharmacological aspects.
New perspectives on calcium antagonists, pp. 1-18
[35.]
E. Braunwaid.
Mechanism of action of calcium channel blocking agents.
N Engl J Med, 307 (1982), pp. 1618-1627
[36.]
G.B. Weiss.
Sites of action of calcium antagonists in vascular smooth muscle.
New perspectives on calcium antagonists, pp. 83-94
[38.]
M. Kanamari, M. Naka, M. Asano, H. Hidaka.
Effects of N-(6-aminohexyl)-5-chloro-l-naphthalenesulfonamide and other calmodulin antagonists (calmodulin interacting agents) on calcium-induced contraction of rabbit aortic strips.
J Pharmacol Exptl Therap, 217 (1981), pp. 494-499
[39.]
E. Antman, J. Muller, S. Goldberg, et al.
Nifedipine therapy for coronary-artery spasm: experience in 127 patients.
N Engl J Med, 302 (1980), pp. 1269-1273
[40.]
B.H. Lorell, W. Paulus, W. Grossman, M.A. Fulton, J. Wynne, P.F. Cohn.
Improved diastolic compliance to hypertrofie cardiomiopathy treated with nifedipine.
Circulation, 62 (1980), pp. 317
[41.]
M.T. Olivari, C. Bartorelli, A. Polese, C. Feorentini, P. Morussin, M.D. Guazzi.
Treatment of hypertension with nifedipine, a calcium antagonistic agent.
Circulation, 59 (1979), pp. 1056-1062
[42.]
M. Bortolotti, G. Labo.
Clinical and manometric effects of nifedipine in patients with esophageal achalasia.
Gastroenterology, 80 (1981), pp. 34-44
[43.]
R.J. Rodheffer, J.A. Rommer, F. Wiglwy, C.R. Smith.
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
N Engl J Med, 308 (1983), pp. 880-883
[44.]
A.M.L. Lever, P.A. Corris, G.J. Gibson.
Nifedipine enhances the bronchodilator effect of salbutamol.
Thorax, 39 (1984), pp. 576-578
[45.]
J. Cortijo, M. Perpiñá, E.J. Morcillo, J. Esplugues.
Pharmacological characterization of the effects of verapamil and nifedipine on isolated guinea-pig lung parenchymal strip.
Gen Pharmac, 17 (1986), pp. 211-217
[46.]
M. Perpiñá, J. Cortijo, E. Morcillo, J. Esplugues.
Efecto de los antagonistas del Ca2+ sobre la contracción histamino-inducida en el músculo traqueal de cobayo.
Arch Bronconeumol, 20 (1948), pp. 14
[47.]
P.J. Barnes, N.M. Wiison, M.J. Brown.
A calcium antagonist, nifedipine, modifies exercise-induced asthma.
Thorax, 36 (1981), pp. 726-730
[48.]
D.O. Williams, P.J. Barnes, H.P. Vickers, M. Rudolph.
Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma.
Br Med J, 283 (1981), pp. 348
[49.]
S. Malik, J. O’Reilly, M.F. Sudiow.
Effects of sublingual nifedipine on inhaled histamine and methacholine-induced bronchoconstriction in atopic subjects.
Thorax, 37 (1982), pp. 230
[50.]
P.A. Corris, S.A. Nariman, G.J. Gibson.
Nifedipine in the prevention of asthma induced by exercise and histamine.
Am Rev Respir Dis, 128 (1983), pp. 991-992
[51.]
V. Marco, B. Togores, M. Perpiñá, C. Pellicer, J. Francés.
Comparison of the efficacy of nifedipine and ipratropium bromide to prevent methacholine-induced bronchoconstriction in asthmatics.
Bull Europ Physiopath Resp, 20 (1984), pp. 49A
[52.]
M. Perpiñá, C. Pellicer, V. Marco.
Nifedipine decreases sensitivity and reactivity to methacholine in mild asthmatics.
Respiration, (1986),
[53.]
D. Patakas, E. Vlachonianni, V. Tsara, G. Louridas, P. Argiropoulou.
Nifedipine in bronchial asthma.
J Allergy Clin Immunol, 72 (1983), pp. 269-273
[54.]
N. Nair, R.G. Townley, A. Bewtra, C.K. Nair.
Safety of nifedipine in subjects with bronchial asthma and COPD.
Chest, 86 (1984), pp. 515-518
[55.]
J.A. Madrigal Vilata, R. Llopis Llombart, J. Merino Sesma, J. Muñoz Gil, L. Insa Pérez, V. López Merino.
Estudio del efecto de la nifedipina sobre las vías aéreas en pacientes afectos de broncopatía obstructiva crónica.
Arch Bronconeumol, 21 (1985), pp. 29-33
[57.]
C.H. Fanta, C.S. Venugopalan, P.G. Lacouture, J.M. Drazen.
Inhibition of bronchoconstriction in the guinea pig by a calcium channel blocker, nifedipine.
Am Rev Respir Dis, 125 (1982), pp. 61-66
[58.]
E.C. Deal Jr., A.D. Cherniack, L.B. Eberlin.
Effects of verapamil on histamine— and carbachol-induced contraction of pulmonary tissues in vitro.
Chest, 86 (1984), pp. 762-766
[59.]
A.F. Henderson, R.W. Heaton, L.S. Dunlop, J.F. Costello.
Effects of nifedipine on antigen-induced bronchoconstriction.
Am Rev Respir Dis, 127 (1983), pp. 549-553
[60.]
J.M. Drazen, C.H. Fanta, P.G. Lacouture.
Effect of nifedipine on constriction of human tracheal strips in vitro.
Br J Pharmacol, 78 (1983), pp. 687-691
[61.]
P.E. Malo, M.A. Wasserman, R.L. Griffin.
Effects of intravenous and aerosol nifedipine on prostaglandin F2a and histamine-induced bronchoconstriction in anesthesized dogs.
J Pharmacol ExpTher, 221 (1982), pp. 410-415
[62.]
T.M. Brugman, M.L. Darnell, C.A. Hirshman.
Nifedipine aerosol attenuates airway constriction in dogs with hyperreactive airways.
Am Rev Respir Dis, 127 (1983), pp. 14-17
[63.]
J.M. González, R.L. Morile, K. Bloom, S. Akers, A.E. Raizner, P.M. Stevens.
Inhibition of airway reactivity by nifedipine in patients with coronary artery disease.
Am Rev Respir Dis, 127 (1983), pp. 155-157
[64.]
J. Cerrina, A. Denjean, G. Alexandre, A. Lockhart, P. Duroux.
Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.
Am Rev Respir Dis, 123 (1981), pp. 156-160
[65.]
E.W. Russi, B. Marchette, L. Yerger, W.M. Abraham, T. Ahmed.
Modification of allergic bronchoconstriction by a calcium antagonist: mode of action.
Am Rev Respir Dis, 127 (1983), pp. 14-17
[66.]
K.R. Patel.
The effect of verapamil on histamine and methacholine-induced bronchoconstriction.
Clin Allergy, 11 (1981), pp. 441-447
[67.]
M.J. Holtzman, J.R. Scheller, M. Dimeo, J.A. Nadel, H.A. Boushey.
Effect of ganglionic blockade on bronchial reactivity in atopic subjects.
Am Rev Respir Dis, 127 (1980), pp. 17-23
[68.]
M. Perpiñá.
Análisis farmacológico de la responsabilidad a autacoides y fármacos autonómicos en la tira de parénquima pulmonar aislado de varias especies animales..
(1981),
[69.]
E. Morcillo, M. Perpiñá, J. Esplugues.
Hyperresponsiveness to autacoids and autonomic drugs in lung parenchymal strips from sensitized guinea-pigs.
Am new Respir Dis, 129 (1984), pp. 948-951
[70.]
S. Kaisner.
A new approach to the measurement and classification of forms of supersensitivity of autonomic effector responses.
Br J Pharmacol, 51 (1974), pp. 427-434
[71.]
W.W. Fleming.
The electrogenic Na+ K+-pump in sooth muscle: physiologic and pharmacologic significance.
Ann Rev Pharmacol Toxicol, 20 (1980), pp. 129-149
[72.]
M. Perpiñá, J. Cortijo, E. Morcillo, J. Esplugues.
Hiperreactividad y calcio. III Reunión Nacional de la Sociedad Española de Patología Respiratoria.
(1983),
[73.]
M. Perpiñá, J. Cortijo, J. Esplugues, E.J. Morcillo.
Different ability of verapamil to inhibit agonist-induced contraction of lung parenchymal strips from control and sensitized guineapigs.
(1986),
[74.]
D.K. Banerjee.
Bronchial hyperreactivity associated with tracheal gangliosides.
Science, 218 (1982), pp. 569-571
[75.]
P. Nath, A.P. Joshi, K.P. AgrawaI.
Biochemical correlates of airway hyperreactivity in guinea-pigs: role of lysophosphatidyl choline.
J Allergy Clin Immunol, 72 (1983), pp. 351-358
[76.]
H.H. Loh.
Law Py. The role of membrane lipids in receptor mechanisms.
Ann Rev Pharmacol Toxicol, 20 (1980), pp. 201-234
[77.]
M. Perpiñá, J. Cortijo, C. Sanz, E. Morcillo, J. Esplugues.
Antagonismo del Ca2+ intracelular en el músculo liso de vías aéreas de cobayo normal y sensibilizado.
Arch Bronconeumol, 21 (1985), pp. 29-30
[78.]
E.B. Weiss.
Toxic oxygen products alter calcium homeostasis in an asthma model.
J Allergy Clin Immunol, 75 (1985), pp. 692-697
[79.]
E.B. Weiss, J.R. Bellino.
Interaction of leucotriene 04 and superoxide anión induce airways hyperreactivity.
Am Rev Respir Dis, 131 (1985),
Copyright © 1987. Sociedad Española de Neumología y Cirugía Torácica
